reports
-
Alzheimer’s & Dementia Care
Anavex Life Sciences Reports Sustained Long-Term Benefits of Oral Blarcamesine in Early Alzheimer’s Disease Over Nearly Three Years
Copenhagen, Denmark – Anavex Life Sciences, a biopharmaceutical company focused on central nervous system disorders, has announced that the therapeutic…
Read More » -
Alzheimer’s & Dementia Care
Study reports Alzheimer’s treatment gains in long-term care
Top-line data emanating from the BEACON study, a real-world observational investigation, indicate that Zunveyl (benzgalantamine) was linked to significant provider-reported…
Read More »
